Brad Setser Joins the President-elect Biden and Vice President-elect Harris Transition Team

Senior Advisor Brad Setser has joined a Biden-Harris agency review team. Setser is a member of the Office of the United States Trade Representative team. This team will also review the US International Trade Commission and the US Trade and Development Agency. As such, Brad will be on leave from his role as Senior Advisor to Exante Data.

According to the Biden-Harris Transition website:

“Agency review teams are responsible for understanding the operations of each agency, ensuring a smooth transfer of power, and preparing for President-elect Biden and Vice President-elect Harris and their cabinet to hit the ground running on Day One. These teams are composed of highly experienced and talented professionals with deep backgrounds in crucial policy areas across the federal government.”  You can learn more about the agency review teams here.

Setser joined Exante Data in mid-2019 as a Senior Advisor – announcement here.  During his time with us, he remained on fellowship with the Council on Foreign Relations.  Setser has been analyzing global capital movements for more than 20 years, and we regard him as one of the world’s top experts on this topic. At Exante Data, we have sought to embed Setser’s analytical approach into our Global Flow Analytics platform – this tool will remain a core part of our client offering into 2021.

“We wish Brad the best in this important policy role, and while we do not know what the future holds, we would like to thank Brad for his contributions to Exante’s research process to date,” said Founder and CEO Jens Nordvig.  “We have learnt a lot from Brad’s deep knowledge of balance of payment trends in many important economies, and we are grateful for his contributions to Exante Data in 2019 and 2020.”

If you have any questions, please reach out to us.

 

Exante Data © 2024. All rights reserved. Personal Data Usage Policy


This site is provided for informational purposes only.  The information included in this site should not be used as the sole basis for making a decision as to whether or not to invest in any particular security. In making an investment decision, you must rely on your own examination of the securities and the terms of the offering. You should not construe the contents of these materials as legal, tax, investment or other advice, or a recommendation to purchase or sell any particular security.

The information included in this site is based upon information reasonably available to Exante as of the date noted herein. Furthermore, the information included in this site has been obtained from sources that Exante believes to be reliable; however, these sources cannot be guaranteed as to their accuracy or completeness. Information contained in this site does not purport to be complete, nor does Exante undertake any duty to update the information set forth herein. No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information contained herein, by Exante, its members, partners or employees, and no liability is accepted by such persons for the accuracy or completeness of any such information.

This site contains certain “forward-looking statements,” which may be identified by the use of such words as “believe,” “expect,” “anticipate,” “should,” “planned,” “estimated,” “potential,” “outlook,” “forecast,” “plan” and other similar terms. Examples of forward-looking statements include, but are not limited to, estimates with respect to financial condition, results of operations, and success or lack of success of certain investment strategy. All are subject to various factors, including, but not limited to, general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting the operations of the companies identified herein, any or all of which could cause actual results to differ materially from projected results.